BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Franco E, Giambi C, Ialacci R, Coppola RC, Zanetti AR. Risk groups for hepatitis A virus infection. Vaccine. 2003;21:2224-2233. [PMID: 12744847 DOI: 10.1016/s0264-410x(03)00137-3] [Cited by in Crossref: 55] [Cited by in F6Publishing: 18] [Article Influence: 3.1] [Reference Citation Analysis]
Number Citing Articles
1 Campagna M, Siddu A, Meloni A, Basciu C, Ferrai L, Pettinau A, Cardia C, Masia G, Coppola RC. Changing pattern of hepatitis a virus epidemiology in an area of high endemicity. Hepat Mon 2012;12:382-5. [PMID: 22879827 DOI: 10.5812/hepatmon.5940] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
2 Kanda T, Sasaki R, Masuzaki R, Takahashi H, Mizutani T, Matsumoto N, Nirei K, Moriyama M. Co-Occurrence of Hepatitis A Infection and Chronic Liver Disease. Int J Mol Sci 2020;21:E6384. [PMID: 32887515 DOI: 10.3390/ijms21176384] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
3 Lange JH, Mastrangelo G, Cegolon L. Infectious disease risk in asbestos abatement workers. BMC Public Health 2012;12:665. [PMID: 22897975 DOI: 10.1186/1471-2458-12-665] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
4 Shin DH, Han SK, Choi PC, Lim SW, Kim KM, Sinn DH. Vaccination rate and seroepidemiology of hepatitis a in chronic-hepatitis-B-infected individuals in the korean army. Gut Liver 2010;4:207-11. [PMID: 20559523 DOI: 10.5009/gnl.2010.4.2.207] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
5 Seo JY, Choi S, Choi B, Ki M. Age-period-cohort analysis of hepatitis A incidence rates in Korea from 2002 to 2012. Epidemiol Health 2016;38:e2016040. [PMID: 27703127 DOI: 10.4178/epih.e2016040] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
6 Blondeel K, Say L, Chou D, Toskin I, Khosla R, Scolaro E, Temmerman M. Evidence and knowledge gaps on the disease burden in sexual and gender minorities: a review of systematic reviews. Int J Equity Health 2016;15:16. [PMID: 26800682 DOI: 10.1186/s12939-016-0304-1] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 5.5] [Reference Citation Analysis]
7 Cho HC, Paik SW, Kim YJ, Choi MS, Lee JH, Koh KC, Yoo BC, Son HJ, Kim SW. Seroprevalence of anti-HAV among patients with chronic viral liver disease. World J Gastroenterol 2011; 17(2): 236-241 [PMID: 21245998 DOI: 10.3748/wjg.v17.i2.236] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
8 Kang CI, Choi CM, Park TS, Lee DJ, Oh MD, Choe KW. Incidence and seroprevalence of hepatitis A virus infections among young Korean soldiers. J Korean Med Sci 2007;22:546-8. [PMID: 17596668 DOI: 10.3346/jkms.2007.22.3.546] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 1.5] [Reference Citation Analysis]
9 Ochnio JJ, Scheifele DW, Fyfe M, Bigham M, Bowering D, Martiquet P, Ho M, Talling DN. The prevalence of hepatitis A in children in British Columbia. Can J Infect Dis Med Microbiol 2005;16:175-9. [PMID: 18159540 DOI: 10.1155/2005/460983] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
10 Siagris D, Kouraklis-Symeonidis A, Konstantinidou I, Christofidou M, Starakis I, Lekkou A, Papadimitriou C, Blikas A, Zoumbos N, Labropoulou-Karatza C. Prevalence of anti-HAV antibodies in multitransfused patients with beta-thalassemia. World J Gastroenterol 2008; 14(10): 1559-1563 [PMID: 18330948 DOI: 10.3748/wjg.14.1559] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
11 Sequera VG, Valencia S, García-Basteiro AL, Marco A, Bayas JM. Vaccinations in prisons: A shot in the arm for community health. Hum Vaccin Immunother 2015;11:2615-26. [PMID: 26158401 DOI: 10.1080/21645515.2015.1051269] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.4] [Reference Citation Analysis]
12 Seo JY, Choi BY, Ki M, Jang HL, Park HS, Son HJ, Bae SH, Kang JH, Jun DW, Lee JW, Hong YJ, Kim YS, Kim CH, Chang UI, Kim JH, Yang HW, Kim HS, Park KB, Hwang JS, Heo J, Kim IH, Kim JS, Cheon GJ. Risk factors for acute hepatitis A infection in Korea in 2007 and 2009: a case-control study. J Korean Med Sci 2013;28:908-14. [PMID: 23772157 DOI: 10.3346/jkms.2013.28.6.908] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
13 Gharbi-Khelifi H, Abid NB, Beji A, Bhiri L, Harrath R, Sdiri K, Billaudel S, Ferre V, Aouni M. Seroprevalence and Molecular Characterisation of Human Hepatitis A virus in Serum Samples of Tunisian Patients with Clinical Symptoms of Viral Hepatitis. Indian J Virol 2012;23:29-35. [PMID: 23729999 DOI: 10.1007/s13337-012-0063-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
14 Franco E, Meleleo C, Serino L, Sorbara D, Zaratti L. Hepatitis A: Epidemiology and prevention in developing countries. World J Hepatol 2012; 4(3): 68-73 [PMID: 22489258 DOI: 10.4254/wjh.v4.i3.68] [Cited by in Crossref: 157] [Cited by in F6Publishing: 112] [Article Influence: 15.7] [Reference Citation Analysis]
15 Cao G, Jing W, Liu J, Liu M. The global trends and regional differences in incidence and mortality of hepatitis A from 1990 to 2019 and implications for its prevention. Hepatol Int 2021. [PMID: 34345993 DOI: 10.1007/s12072-021-10232-4] [Reference Citation Analysis]
16 Lin KY, Chen GJ, Lee YL, Huang YC, Cheng A, Sun HY, Chang SY, Liu CE, Hung CC. Hepatitis A virus infection and hepatitis A vaccination in human immunodeficiency virus-positive patients: A review. World J Gastroenterol 2017; 23(20): 3589-3606 [PMID: 28611512 DOI: 10.3748/wjg.v23.i20.3589] [Cited by in CrossRef: 51] [Cited by in F6Publishing: 46] [Article Influence: 10.2] [Reference Citation Analysis]
17 Vasylyeva TI, Smyrnov P, Strathdee S, Friedman SR. Challenges posed by COVID-19 to people who inject drugs and lessons from other outbreaks. J Int AIDS Soc 2020;23:e25583. [PMID: 32697423 DOI: 10.1002/jia2.25583] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 11.5] [Reference Citation Analysis]
18 Mena G, García-Basteiro AL, Bayas JM. Hepatitis B and A vaccination in HIV-infected adults: A review. Hum Vaccin Immunother 2015;11:2582-98. [PMID: 26208678 DOI: 10.1080/21645515.2015.1055424] [Cited by in Crossref: 43] [Cited by in F6Publishing: 37] [Article Influence: 6.1] [Reference Citation Analysis]